WCG IPO Presentation Deck

Majority of Growth Achieved Organically - As Evidenced by EBITDA Bridge Transformational Company Building EBITDA* ($ millions) 15 IRB CSO 2012 Adj EBITDA Margin 29% 2012 2012-14 2014-16 2016 2017 WIRBCopernicus IRBNetpharmsolutions fil ProPhase ThreaWire Aspireirb Midlands he New Clintrax Global karmadata CenterWatch ALLIANCE 2017 Organic EBITDA Growth (2012-20) 2017 FDANEWS ConsentNow VIGILARE MedAvante. KMR GROUP 2018 2019 2020 ACI AANALGESIC trifecta MCC pharmaseek Statistics-Collaborative DNL wcg 2020A wcg Adj EBITDA Margin >45%

View entire presentation